Sign in
4

Changes in Ownership

VERTEX PHARMACEUTICALS INC / MA Filed Acc 0000875320-26-000004

EVP, Chief Reg. & Quality Off. sold 4,500 shares at $474.99 ($2,137,455)

  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Tatsis Ourania · EVP, Chief Reg. & Quality Off.

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2026-01-07 Sale : show line 1 in the form 10b5-1 −4,500 $474.99 $2,137,455 42,293 D
Open-market sales · 4,500 sh · avg $474.99 · $2,137,455
Loading xslF345X05/wk-form4_1767992722.xml…